Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project
一项由研究者发起的 II 期研究,评估 Brentuximab Vedotin 在 CD30 表达水平各异的蕈样肉芽肿和 Sézary 综合征中的疗效:一项多机构合作项目
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2014.60.3969
Kim, Youn H; Tavallaee, Mahkam; Sundram, Uma; Salva, Katrin A; Wood, Gary S; Li, Shufeng; Rozati, Sima; Nagpal, Seema; Krathen, Michael; Reddy, Sunil; Hoppe, Richard T; Nguyen-Lin, Annie; Weng, Wen-Kai; Armstrong, Randall; Pulitzer, Melissa; Advani, Ranjana H; Horwitz, Steven M